Global Biopreservation

Biopreservation Comprehensive Study by Type (Biopreservation Media, Biopreservation Equipment, Others), Application (Biobanking, Regenerative Medicine, Drug Discovery, Others), End Users (Biobanks, Hospitals, Others) Players and Region - Global Market Outlook to 2030

Biopreservation Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 21.6%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Biopreservation Market Scope
Biopreservation involves preserving biological materials, like cells, tissues, or organs, using diverse techniques to prolong their viability and functionality. The primary objective is to impede or decelerate the deterioration of biological samples, enabling their extended storage without substantial loss of quality. The biopreservation market is propelled by a heightened demand for organ transplants, continuous advancements in regenerative medicine, and the widespread expansion of biobanking initiatives. Technological breakthroughs, particularly in the domains of cryopreservation and vitrification, continue to drive the market forward. Despite these positive dynamics, the industry grapples with obstacles, including ethical and regulatory complexities, the substantial costs linked to advanced techniques, and a lack of awareness in developing regions. Noteworthy trends within the market involve a growing reliance on automated systems, a concentrated emphasis on personalized medicine, and the integration of artificial intelligence to enhance biopreservation protocols.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledBioCision LLC (California), BioLife Solutions Inc. (United States), Cesca Therapeutics Inc. (California), Core Dynamics Ltd (United States), Custom Biogenic System Inc. (United States), Lifeline Scientific Inc. (United States), Merck KGaA (Germany), Princeton CryoTech Inc. (United States), VWR International (United States), Azenta US Inc. (United States) and Thermo Fisher Scientific Inc.(United States)
CAGR21.6%


The biopreservation market is slightly fragmented due to the presence of a few companies operating globally and regionally. The competitive landscape includes an analysis of a few international and local companies that hold market Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Biopreservation market throughout the predicted period.

BioCision LLC (California), BioLife Solutions Inc. (United States), Cesca Therapeutics Inc. (California), Core Dynamics Ltd (United States), Custom Biogenic System Inc. (United States), Lifeline Scientific Inc. (United States), Merck KGaA (Germany), Princeton CryoTech Inc. (United States), VWR International (United States), Azenta US Inc. (United States) and Thermo Fisher Scientific Inc.(United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are So-Low Environmental Equipment (United States), BioLife Solutions (United States), Eppendorf North America (Germany), Chart MVE BioMedical (United States), Thermo Fisher Scientific (United States), Biomatrica (United States) and Panasonic Healthcare (America).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Biopreservation market by Type , by Application (Biobanking, Regenerative Medicine, Drug Discovery and Others) and Region with country level break-up.

On the basis of geography, the market of Biopreservation has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies
In May, 2021 BioLife Solutions, Inc., a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, announced that it has closed the previously announced acquisition of Stirling Ultracold (Stirling), a privately held manufacturer of ultra-low temperature mechanical freezers.
In October 2023 BioLife Solutions Inc. a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy and broader biopharma markets, announced Roderick de Greef has been appointed as Chairman of the Board of Directors and Chief Executive Officer replacing Michael Rice who is retiring after a seventeen-year tenure, effective immediately.


Influencing Trend:
Increasing Use of Automated Systems and Growing Interest in Personalized Medicine

Market Growth Drivers:
Increasing Demand for Organ Transplants and Advancements in Regenerative Medicine

Challenges:
establishing standardized protocols for biopreservation across different biological materials and biological material may pose unique challenges in terms of preservation requiring tailored solutions

Restraints:
Stringent regulations and ethical concerns related to the preservation of certain biological materials pose constraints. and High Costs Associated with Advanced Techniques

Opportunities:
Opportunities arise with the expanding stem cell banking sector requiring efficient biopreservation solutions and Increased collaborations between biopreservation companies and research institutions present growth opportunities

Key Target Audience
Research Development, Stockholder, Manufacturing, Bio-preservation, Regulatory Agencies and Others

Report Objectives / Segmentation Covered

By Type
  • Biopreservation Media
  • Biopreservation Equipment
  • Others
By Application
  • Biobanking
  • Regenerative Medicine
  • Drug Discovery
  • Others
By End Users
  • Biobanks
  • Hospitals
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Demand for Organ Transplants
      • 3.2.2. Advancements in Regenerative Medicine
    • 3.3. Market Challenges
      • 3.3.1. Establishing standardized protocols for biopreservation across different biological materials
      • 3.3.2. Biological material may pose unique challenges in terms of preservation requiring tailored solutions
    • 3.4. Market Trends
      • 3.4.1. Increasing Use of Automated Systems
      • 3.4.2. Growing Interest in Personalized Medicine
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Biopreservation, by Type, Application, End Users and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Biopreservation (Value)
      • 5.2.1. Global Biopreservation by: Type (Value)
        • 5.2.1.1. Biopreservation Media
        • 5.2.1.2. Biopreservation Equipment
        • 5.2.1.3. Others
      • 5.2.2. Global Biopreservation by: Application (Value)
        • 5.2.2.1. Biobanking
        • 5.2.2.2. Regenerative Medicine
        • 5.2.2.3. Drug Discovery
        • 5.2.2.4. Others
      • 5.2.3. Global Biopreservation by: End Users (Value)
        • 5.2.3.1. Biobanks
        • 5.2.3.2. Hospitals
        • 5.2.3.3. Others
      • 5.2.4. Global Biopreservation Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Biopreservation: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. BioCision LLC (California)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. BioLife Solutions Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cesca Therapeutics Inc. (California)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Core Dynamics Ltd (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Custom Biogenic System Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Lifeline Scientific Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Merck KGaA (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Princeton CryoTech Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. VWR International (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Azenta US Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Thermo Fisher Scientific Inc.(United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Biopreservation Sale, by Type, Application, End Users and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Biopreservation (Value)
      • 7.2.1. Global Biopreservation by: Type (Value)
        • 7.2.1.1. Biopreservation Media
        • 7.2.1.2. Biopreservation Equipment
        • 7.2.1.3. Others
      • 7.2.2. Global Biopreservation by: Application (Value)
        • 7.2.2.1. Biobanking
        • 7.2.2.2. Regenerative Medicine
        • 7.2.2.3. Drug Discovery
        • 7.2.2.4. Others
      • 7.2.3. Global Biopreservation by: End Users (Value)
        • 7.2.3.1. Biobanks
        • 7.2.3.2. Hospitals
        • 7.2.3.3. Others
      • 7.2.4. Global Biopreservation Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Biopreservation: by Type(USD Million)
  • Table 2. Biopreservation Biopreservation Media , by Region USD Million (2018-2023)
  • Table 3. Biopreservation Biopreservation Equipment , by Region USD Million (2018-2023)
  • Table 4. Biopreservation Others , by Region USD Million (2018-2023)
  • Table 5. Biopreservation: by Application(USD Million)
  • Table 6. Biopreservation Biobanking , by Region USD Million (2018-2023)
  • Table 7. Biopreservation Regenerative Medicine , by Region USD Million (2018-2023)
  • Table 8. Biopreservation Drug Discovery , by Region USD Million (2018-2023)
  • Table 9. Biopreservation Others , by Region USD Million (2018-2023)
  • Table 10. Biopreservation: by End Users(USD Million)
  • Table 11. Biopreservation Biobanks , by Region USD Million (2018-2023)
  • Table 12. Biopreservation Hospitals , by Region USD Million (2018-2023)
  • Table 13. Biopreservation Others , by Region USD Million (2018-2023)
  • Table 14. South America Biopreservation, by Country USD Million (2018-2023)
  • Table 15. South America Biopreservation, by Type USD Million (2018-2023)
  • Table 16. South America Biopreservation, by Application USD Million (2018-2023)
  • Table 17. South America Biopreservation, by End Users USD Million (2018-2023)
  • Table 18. Brazil Biopreservation, by Type USD Million (2018-2023)
  • Table 19. Brazil Biopreservation, by Application USD Million (2018-2023)
  • Table 20. Brazil Biopreservation, by End Users USD Million (2018-2023)
  • Table 21. Argentina Biopreservation, by Type USD Million (2018-2023)
  • Table 22. Argentina Biopreservation, by Application USD Million (2018-2023)
  • Table 23. Argentina Biopreservation, by End Users USD Million (2018-2023)
  • Table 24. Rest of South America Biopreservation, by Type USD Million (2018-2023)
  • Table 25. Rest of South America Biopreservation, by Application USD Million (2018-2023)
  • Table 26. Rest of South America Biopreservation, by End Users USD Million (2018-2023)
  • Table 27. Asia Pacific Biopreservation, by Country USD Million (2018-2023)
  • Table 28. Asia Pacific Biopreservation, by Type USD Million (2018-2023)
  • Table 29. Asia Pacific Biopreservation, by Application USD Million (2018-2023)
  • Table 30. Asia Pacific Biopreservation, by End Users USD Million (2018-2023)
  • Table 31. China Biopreservation, by Type USD Million (2018-2023)
  • Table 32. China Biopreservation, by Application USD Million (2018-2023)
  • Table 33. China Biopreservation, by End Users USD Million (2018-2023)
  • Table 34. Japan Biopreservation, by Type USD Million (2018-2023)
  • Table 35. Japan Biopreservation, by Application USD Million (2018-2023)
  • Table 36. Japan Biopreservation, by End Users USD Million (2018-2023)
  • Table 37. India Biopreservation, by Type USD Million (2018-2023)
  • Table 38. India Biopreservation, by Application USD Million (2018-2023)
  • Table 39. India Biopreservation, by End Users USD Million (2018-2023)
  • Table 40. South Korea Biopreservation, by Type USD Million (2018-2023)
  • Table 41. South Korea Biopreservation, by Application USD Million (2018-2023)
  • Table 42. South Korea Biopreservation, by End Users USD Million (2018-2023)
  • Table 43. Taiwan Biopreservation, by Type USD Million (2018-2023)
  • Table 44. Taiwan Biopreservation, by Application USD Million (2018-2023)
  • Table 45. Taiwan Biopreservation, by End Users USD Million (2018-2023)
  • Table 46. Australia Biopreservation, by Type USD Million (2018-2023)
  • Table 47. Australia Biopreservation, by Application USD Million (2018-2023)
  • Table 48. Australia Biopreservation, by End Users USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Biopreservation, by Type USD Million (2018-2023)
  • Table 50. Rest of Asia-Pacific Biopreservation, by Application USD Million (2018-2023)
  • Table 51. Rest of Asia-Pacific Biopreservation, by End Users USD Million (2018-2023)
  • Table 52. Europe Biopreservation, by Country USD Million (2018-2023)
  • Table 53. Europe Biopreservation, by Type USD Million (2018-2023)
  • Table 54. Europe Biopreservation, by Application USD Million (2018-2023)
  • Table 55. Europe Biopreservation, by End Users USD Million (2018-2023)
  • Table 56. Germany Biopreservation, by Type USD Million (2018-2023)
  • Table 57. Germany Biopreservation, by Application USD Million (2018-2023)
  • Table 58. Germany Biopreservation, by End Users USD Million (2018-2023)
  • Table 59. France Biopreservation, by Type USD Million (2018-2023)
  • Table 60. France Biopreservation, by Application USD Million (2018-2023)
  • Table 61. France Biopreservation, by End Users USD Million (2018-2023)
  • Table 62. Italy Biopreservation, by Type USD Million (2018-2023)
  • Table 63. Italy Biopreservation, by Application USD Million (2018-2023)
  • Table 64. Italy Biopreservation, by End Users USD Million (2018-2023)
  • Table 65. United Kingdom Biopreservation, by Type USD Million (2018-2023)
  • Table 66. United Kingdom Biopreservation, by Application USD Million (2018-2023)
  • Table 67. United Kingdom Biopreservation, by End Users USD Million (2018-2023)
  • Table 68. Netherlands Biopreservation, by Type USD Million (2018-2023)
  • Table 69. Netherlands Biopreservation, by Application USD Million (2018-2023)
  • Table 70. Netherlands Biopreservation, by End Users USD Million (2018-2023)
  • Table 71. Rest of Europe Biopreservation, by Type USD Million (2018-2023)
  • Table 72. Rest of Europe Biopreservation, by Application USD Million (2018-2023)
  • Table 73. Rest of Europe Biopreservation, by End Users USD Million (2018-2023)
  • Table 74. MEA Biopreservation, by Country USD Million (2018-2023)
  • Table 75. MEA Biopreservation, by Type USD Million (2018-2023)
  • Table 76. MEA Biopreservation, by Application USD Million (2018-2023)
  • Table 77. MEA Biopreservation, by End Users USD Million (2018-2023)
  • Table 78. Middle East Biopreservation, by Type USD Million (2018-2023)
  • Table 79. Middle East Biopreservation, by Application USD Million (2018-2023)
  • Table 80. Middle East Biopreservation, by End Users USD Million (2018-2023)
  • Table 81. Africa Biopreservation, by Type USD Million (2018-2023)
  • Table 82. Africa Biopreservation, by Application USD Million (2018-2023)
  • Table 83. Africa Biopreservation, by End Users USD Million (2018-2023)
  • Table 84. North America Biopreservation, by Country USD Million (2018-2023)
  • Table 85. North America Biopreservation, by Type USD Million (2018-2023)
  • Table 86. North America Biopreservation, by Application USD Million (2018-2023)
  • Table 87. North America Biopreservation, by End Users USD Million (2018-2023)
  • Table 88. United States Biopreservation, by Type USD Million (2018-2023)
  • Table 89. United States Biopreservation, by Application USD Million (2018-2023)
  • Table 90. United States Biopreservation, by End Users USD Million (2018-2023)
  • Table 91. Canada Biopreservation, by Type USD Million (2018-2023)
  • Table 92. Canada Biopreservation, by Application USD Million (2018-2023)
  • Table 93. Canada Biopreservation, by End Users USD Million (2018-2023)
  • Table 94. Mexico Biopreservation, by Type USD Million (2018-2023)
  • Table 95. Mexico Biopreservation, by Application USD Million (2018-2023)
  • Table 96. Mexico Biopreservation, by End Users USD Million (2018-2023)
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Biopreservation: by Type(USD Million)
  • Table 109. Biopreservation Biopreservation Media , by Region USD Million (2025-2030)
  • Table 110. Biopreservation Biopreservation Equipment , by Region USD Million (2025-2030)
  • Table 111. Biopreservation Others , by Region USD Million (2025-2030)
  • Table 112. Biopreservation: by Application(USD Million)
  • Table 113. Biopreservation Biobanking , by Region USD Million (2025-2030)
  • Table 114. Biopreservation Regenerative Medicine , by Region USD Million (2025-2030)
  • Table 115. Biopreservation Drug Discovery , by Region USD Million (2025-2030)
  • Table 116. Biopreservation Others , by Region USD Million (2025-2030)
  • Table 117. Biopreservation: by End Users(USD Million)
  • Table 118. Biopreservation Biobanks , by Region USD Million (2025-2030)
  • Table 119. Biopreservation Hospitals , by Region USD Million (2025-2030)
  • Table 120. Biopreservation Others , by Region USD Million (2025-2030)
  • Table 121. South America Biopreservation, by Country USD Million (2025-2030)
  • Table 122. South America Biopreservation, by Type USD Million (2025-2030)
  • Table 123. South America Biopreservation, by Application USD Million (2025-2030)
  • Table 124. South America Biopreservation, by End Users USD Million (2025-2030)
  • Table 125. Brazil Biopreservation, by Type USD Million (2025-2030)
  • Table 126. Brazil Biopreservation, by Application USD Million (2025-2030)
  • Table 127. Brazil Biopreservation, by End Users USD Million (2025-2030)
  • Table 128. Argentina Biopreservation, by Type USD Million (2025-2030)
  • Table 129. Argentina Biopreservation, by Application USD Million (2025-2030)
  • Table 130. Argentina Biopreservation, by End Users USD Million (2025-2030)
  • Table 131. Rest of South America Biopreservation, by Type USD Million (2025-2030)
  • Table 132. Rest of South America Biopreservation, by Application USD Million (2025-2030)
  • Table 133. Rest of South America Biopreservation, by End Users USD Million (2025-2030)
  • Table 134. Asia Pacific Biopreservation, by Country USD Million (2025-2030)
  • Table 135. Asia Pacific Biopreservation, by Type USD Million (2025-2030)
  • Table 136. Asia Pacific Biopreservation, by Application USD Million (2025-2030)
  • Table 137. Asia Pacific Biopreservation, by End Users USD Million (2025-2030)
  • Table 138. China Biopreservation, by Type USD Million (2025-2030)
  • Table 139. China Biopreservation, by Application USD Million (2025-2030)
  • Table 140. China Biopreservation, by End Users USD Million (2025-2030)
  • Table 141. Japan Biopreservation, by Type USD Million (2025-2030)
  • Table 142. Japan Biopreservation, by Application USD Million (2025-2030)
  • Table 143. Japan Biopreservation, by End Users USD Million (2025-2030)
  • Table 144. India Biopreservation, by Type USD Million (2025-2030)
  • Table 145. India Biopreservation, by Application USD Million (2025-2030)
  • Table 146. India Biopreservation, by End Users USD Million (2025-2030)
  • Table 147. South Korea Biopreservation, by Type USD Million (2025-2030)
  • Table 148. South Korea Biopreservation, by Application USD Million (2025-2030)
  • Table 149. South Korea Biopreservation, by End Users USD Million (2025-2030)
  • Table 150. Taiwan Biopreservation, by Type USD Million (2025-2030)
  • Table 151. Taiwan Biopreservation, by Application USD Million (2025-2030)
  • Table 152. Taiwan Biopreservation, by End Users USD Million (2025-2030)
  • Table 153. Australia Biopreservation, by Type USD Million (2025-2030)
  • Table 154. Australia Biopreservation, by Application USD Million (2025-2030)
  • Table 155. Australia Biopreservation, by End Users USD Million (2025-2030)
  • Table 156. Rest of Asia-Pacific Biopreservation, by Type USD Million (2025-2030)
  • Table 157. Rest of Asia-Pacific Biopreservation, by Application USD Million (2025-2030)
  • Table 158. Rest of Asia-Pacific Biopreservation, by End Users USD Million (2025-2030)
  • Table 159. Europe Biopreservation, by Country USD Million (2025-2030)
  • Table 160. Europe Biopreservation, by Type USD Million (2025-2030)
  • Table 161. Europe Biopreservation, by Application USD Million (2025-2030)
  • Table 162. Europe Biopreservation, by End Users USD Million (2025-2030)
  • Table 163. Germany Biopreservation, by Type USD Million (2025-2030)
  • Table 164. Germany Biopreservation, by Application USD Million (2025-2030)
  • Table 165. Germany Biopreservation, by End Users USD Million (2025-2030)
  • Table 166. France Biopreservation, by Type USD Million (2025-2030)
  • Table 167. France Biopreservation, by Application USD Million (2025-2030)
  • Table 168. France Biopreservation, by End Users USD Million (2025-2030)
  • Table 169. Italy Biopreservation, by Type USD Million (2025-2030)
  • Table 170. Italy Biopreservation, by Application USD Million (2025-2030)
  • Table 171. Italy Biopreservation, by End Users USD Million (2025-2030)
  • Table 172. United Kingdom Biopreservation, by Type USD Million (2025-2030)
  • Table 173. United Kingdom Biopreservation, by Application USD Million (2025-2030)
  • Table 174. United Kingdom Biopreservation, by End Users USD Million (2025-2030)
  • Table 175. Netherlands Biopreservation, by Type USD Million (2025-2030)
  • Table 176. Netherlands Biopreservation, by Application USD Million (2025-2030)
  • Table 177. Netherlands Biopreservation, by End Users USD Million (2025-2030)
  • Table 178. Rest of Europe Biopreservation, by Type USD Million (2025-2030)
  • Table 179. Rest of Europe Biopreservation, by Application USD Million (2025-2030)
  • Table 180. Rest of Europe Biopreservation, by End Users USD Million (2025-2030)
  • Table 181. MEA Biopreservation, by Country USD Million (2025-2030)
  • Table 182. MEA Biopreservation, by Type USD Million (2025-2030)
  • Table 183. MEA Biopreservation, by Application USD Million (2025-2030)
  • Table 184. MEA Biopreservation, by End Users USD Million (2025-2030)
  • Table 185. Middle East Biopreservation, by Type USD Million (2025-2030)
  • Table 186. Middle East Biopreservation, by Application USD Million (2025-2030)
  • Table 187. Middle East Biopreservation, by End Users USD Million (2025-2030)
  • Table 188. Africa Biopreservation, by Type USD Million (2025-2030)
  • Table 189. Africa Biopreservation, by Application USD Million (2025-2030)
  • Table 190. Africa Biopreservation, by End Users USD Million (2025-2030)
  • Table 191. North America Biopreservation, by Country USD Million (2025-2030)
  • Table 192. North America Biopreservation, by Type USD Million (2025-2030)
  • Table 193. North America Biopreservation, by Application USD Million (2025-2030)
  • Table 194. North America Biopreservation, by End Users USD Million (2025-2030)
  • Table 195. United States Biopreservation, by Type USD Million (2025-2030)
  • Table 196. United States Biopreservation, by Application USD Million (2025-2030)
  • Table 197. United States Biopreservation, by End Users USD Million (2025-2030)
  • Table 198. Canada Biopreservation, by Type USD Million (2025-2030)
  • Table 199. Canada Biopreservation, by Application USD Million (2025-2030)
  • Table 200. Canada Biopreservation, by End Users USD Million (2025-2030)
  • Table 201. Mexico Biopreservation, by Type USD Million (2025-2030)
  • Table 202. Mexico Biopreservation, by Application USD Million (2025-2030)
  • Table 203. Mexico Biopreservation, by End Users USD Million (2025-2030)
  • Table 204. Research Programs/Design for This Report
  • Table 205. Key Data Information from Secondary Sources
  • Table 206. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Biopreservation: by Type USD Million (2018-2023)
  • Figure 5. Global Biopreservation: by Application USD Million (2018-2023)
  • Figure 6. Global Biopreservation: by End Users USD Million (2018-2023)
  • Figure 7. South America Biopreservation Share (%), by Country
  • Figure 8. Asia Pacific Biopreservation Share (%), by Country
  • Figure 9. Europe Biopreservation Share (%), by Country
  • Figure 10. MEA Biopreservation Share (%), by Country
  • Figure 11. North America Biopreservation Share (%), by Country
  • Figure 12. Global Biopreservation share by Players 2023 (%)
  • Figure 13. Global Biopreservation share by Players (Top 3) 2023(%)
  • Figure 14. Global Biopreservation share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. BioCision LLC (California) Revenue, Net Income and Gross profit
  • Figure 17. BioCision LLC (California) Revenue: by Geography 2023
  • Figure 18. BioLife Solutions Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. BioLife Solutions Inc. (United States) Revenue: by Geography 2023
  • Figure 20. Cesca Therapeutics Inc. (California) Revenue, Net Income and Gross profit
  • Figure 21. Cesca Therapeutics Inc. (California) Revenue: by Geography 2023
  • Figure 22. Core Dynamics Ltd (United States) Revenue, Net Income and Gross profit
  • Figure 23. Core Dynamics Ltd (United States) Revenue: by Geography 2023
  • Figure 24. Custom Biogenic System Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Custom Biogenic System Inc. (United States) Revenue: by Geography 2023
  • Figure 26. Lifeline Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Lifeline Scientific Inc. (United States) Revenue: by Geography 2023
  • Figure 28. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 29. Merck KGaA (Germany) Revenue: by Geography 2023
  • Figure 30. Princeton CryoTech Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Princeton CryoTech Inc. (United States) Revenue: by Geography 2023
  • Figure 32. VWR International (United States) Revenue, Net Income and Gross profit
  • Figure 33. VWR International (United States) Revenue: by Geography 2023
  • Figure 34. Azenta US Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. Azenta US Inc. (United States) Revenue: by Geography 2023
  • Figure 36. Thermo Fisher Scientific Inc.(United States) Revenue, Net Income and Gross profit
  • Figure 37. Thermo Fisher Scientific Inc.(United States) Revenue: by Geography 2023
  • Figure 38. Global Biopreservation: by Type USD Million (2025-2030)
  • Figure 39. Global Biopreservation: by Application USD Million (2025-2030)
  • Figure 40. Global Biopreservation: by End Users USD Million (2025-2030)
  • Figure 41. South America Biopreservation Share (%), by Country
  • Figure 42. Asia Pacific Biopreservation Share (%), by Country
  • Figure 43. Europe Biopreservation Share (%), by Country
  • Figure 44. MEA Biopreservation Share (%), by Country
  • Figure 45. North America Biopreservation Share (%), by Country
List of companies from research coverage that are profiled in the study
  • BioCision LLC (California)
  • BioLife Solutions Inc. (United States)
  • Cesca Therapeutics Inc. (California)
  • Core Dynamics Ltd (United States)
  • Custom Biogenic System Inc. (United States)
  • Lifeline Scientific Inc. (United States)
  • Merck KGaA (Germany)
  • Princeton CryoTech Inc. (United States)
  • VWR International (United States)
  • Azenta US Inc. (United States)
  • Thermo Fisher Scientific Inc.(United States)
Additional players considered in the study are as follows:
So-Low Environmental Equipment (United States) , BioLife Solutions (United States) , Eppendorf North America (Germany) , Chart MVE BioMedical (United States) , Thermo Fisher Scientific (United States) , Biomatrica (United States) , Panasonic Healthcare (America)
Select User Access Type

Key Highlights of Report


Jan 2024 239 Pages 52 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Biopreservation Quantitative research analysis
Global Biopreservation Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Biopreservation Market are by type [Biopreservation Media, Biopreservation Equipment and Others], by end use application [Biobanking, Regenerative Medicine, Drug Discovery and Others].
The Biopreservation Market is gaining popularity and expected to see strong valuation by 2030.
  • Increasing Demand for Organ Transplants
  • Advancements in Regenerative Medicine

Know More About Global Biopreservation Report?

Have a Query? Click Here

Other Related Reports

Chromatography Based Cannabis Comprehensive Study by Type (High-Performance Liquid Chromatography, Gas Chromatography, Supercritical Fluid Chromatography, Thin Layer Chromatography), Application (Pai...
$ 3350
Pathological Examination Comprehensive Study by Type (Traditional Pathology, Digital Pathology), Application (Digestive Organs, Other), Testing Services (Anatomic Pathology, Surgical Pathology, Cytop...
$ 3350
HIV-AIDS Diagnostics Comprehensive Study by Type (Assay, Kit, Reagent, Instrument, Software, Services, Others), Application (Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings, Other...
$ 3350
Healthcare Contract Research Outsourcing Comprehensive Study by Service (Clinical Trial Service, Regulatory Service, Clinical Data Management & Biometrics, Medical Writing, Site Management Protocol, ...
$ 3750
Private Healthcare Comprehensive Study by Application (Hospitals, Pharmaceutical Industries, Medical Devices, Health Insurance, Medical Devices and Equipment, Others), Services (Curative, Preventive,...
$ 3350
Rickets Treatment Comprehensive Study by Type (Vitamin D-Related Rickets, Minerals Related Rickets), End User (Hospital, Clinics) Players and Region - Global Market Outlook to 2026
$ 3500